S6P mutation in Delta and Omicron variant spike protein significantly enhances the efficacy of mRNA COVID-19 vaccines.

Saved in:
Bibliographic Details
Title: S6P mutation in Delta and Omicron variant spike protein significantly enhances the efficacy of mRNA COVID-19 vaccines.
Authors: Bong YS; RNAimmune, Inc., Germantown, MD, United States., Brown D; RNAimmune, Inc., Germantown, MD, United States., Chung E; RNAimmune, Inc., Germantown, MD, United States., Ananthaswamy N; RNAimmune, Inc., Germantown, MD, United States., Chen R; RNAimmune, Inc., Germantown, MD, United States.; Guangzhou RNAimmune, Ltd., Guangzhou, China., Lewoczko E; RNAimmune, Inc., Germantown, MD, United States., Sabbers W; RNAimmune, Inc., Germantown, MD, United States., Patterson-Orazem AC; RNAimmune, Inc., Germantown, MD, United States., Dorsey Z; RNAimmune, Inc., Germantown, MD, United States., Zou Y; Guangzhou RNAimmune, Ltd., Guangzhou, China., Yu X; Guangzhou RNAimmune, Ltd., Guangzhou, China., Liang J; Guangzhou RNAimmune, Ltd., Guangzhou, China., He J; Guangzhou RNAimmune, Ltd., Guangzhou, China., Long S; RNAimmune, Inc., Germantown, MD, United States., Shen D; RNAimmune, Inc., Germantown, MD, United States.
Source: Frontiers in immunology [Front Immunol] 2025 Jan 03; Vol. 15, pp. 1495561. Date of Electronic Publication: 2025 Jan 03 (Print Publication: 2024).
Publication Type: Journal Article
Journal Info: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:1664-3224
DOI:10.3389/fimmu.2024.1495561